Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

We are looking forward to welcoming Dr Ben Seymour to our Wellcome Centre for Integrative Neuroimaging.

Dr Seymour has received a Senior Research Fellowship in Clinical Science on ‘Neural mechanisms of endogenous analgesia’. His appointment is a joint one between the Nuffield Department of Clinical Neurosciences and the Oxford Institute for Biomedical Engineering and will start on 1 April 2020.

'I am excited to join so many young and creative colleagues working in Oxford, especially with respect to the existing strengths in pain and computational neuroscience. I'm looking forward to developing many new collaborations across the clinical and engineering spectrum'.
- Ben Seymour

BenSeymour.jpgBen's work addresses the computational and systems neuroscience of pain. This research is part theoretical: building realistic models of neuronal information processes to understand processes of pain perception and behaviour, and part experimental: testing these theories using a range of experimental methodologies, especially fMRI.

A particular focus of his research is on endogenous analgesia: understanding why pain is modulated by so many factors, and how this helps the pain system optimise protection against arm. Ultimately, this research aims to develop new technology-based therapies for treating pain in clinical populations.

Similar stories

Bioelectronic implant offers an intelligent therapy to treat incontinence

The first participants in a clinical trial of a bioelectrical therapy to treat incontinence have received their 'smart' bioelectronic implants.

Direct evidence of reduced NMDA receptors in people with form of encephalitis

NMDAR-antibody encephalitis is an autoimmune brain condition caused by patient’s own antibodies that bind to NMDA (N-Methyl-D-Aspartate) receptors in the synapses between nerve cells.

Director of MRC Brain Network Dynamics Unit appointed

From 2 January 2023, Professor Peter Magill will lead the Medical Research Council Brain Network Dynamics Unit (MRC BNDU) at the University of Oxford.

Study reveals association between diagnosis of a neuropsychiatric condition and severe outcome from COVID-19 infection, and other severe acute respiratory infections

New research from the University of Oxford has shown an increased risk of severe illness and death from both COVID-19 and other severe respiratory infections, such as influenza and pneumonia, among people with a pre-existing mental health condition.

New study shows clinical symptoms for Alzheimer’s can be predicted in preclinical models

Establishing preclinical models of Alzheimer’s that reflect in-life clinical symptoms of each individual is a critically important goal, yet so far it has not been fully realised. A new collaborative study from the University of Oxford has demonstrated that clinical vulnerability to an abnormally abundant protein in Alzheimer’s brain is in fact reflected in individual patient induced pluripotent stem cell-derived cortical neurons.